The Pentostatin Plus Cyclophosphamide (PC) Non-myeloablative Regimen Induces Durable Host T Cell Functional Deficits and Prevents Murine Marrow Allograft Rejection

類似資料

• Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway
  著者:: Mariotti, Jacopo, 等
  出版事項: (2008)
• Pentostatin Plus Cyclophosphamide Safely and Effectively Prevents Immunotoxin Immunogenicity in Murine Hosts
  著者:: Mossoba, Miriam E., 等
  出版事項: (2011)
• Pentostatin, Cyclophosphamide and Rituximab (PCR) Regimen
  著者:: Solimando, Dominic A., 等
  出版事項: (2016)
• The combined use of antilymphocyte serum and cyclophosphamide to suppress renal allograft rejection in the rat.
  著者:: Winearls, C G, 等
  出版事項: (1979)
• High-Dose Sirolimus And Immune Selective Pentostatin Plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-Versus-Tumor Responses
  著者:: Mossoba, Miriam E., 等
  出版事項: (2015)